- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
T cell receptor-engineered T cells for leukemia immunotherapy ; volume:19 ; number:1 ; day:3 ; month:1 ; year:2019 ; pages:1-7 ; date:12.2019
Cancer cell international ; 19, Heft 1 (3.1.2019), 1-7, 12.2019
- Creator
-
Zhang, Yikai
Li, Yangqiu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-018-0720-y
- URN
-
urn:nbn:de:101:1-2019020803015542507153
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Yikai
- Li, Yangqiu
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
mRNA‐Engineered CD5‐CAR‐γδT CD5‐ Cells for the Immunotherapy of T‐Cell Acute Lymphoblastic Leukemia
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Optimization of adoptive immunotherapy with genetically engineered T cells
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
mRNA‐Engineered CD5‐CAR‐γδT CD5‐ Cells for the Immunotherapy of T‐Cell Acute Lymphoblastic Leukemia
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Optimization of adoptive immunotherapy with genetically engineered T cells
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
mRNA‐Engineered CD5‐CAR‐γδT CD5‐ Cells for the Immunotherapy of T‐Cell Acute Lymphoblastic Leukemia
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Optimization of adoptive immunotherapy with genetically engineered T cells
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)